C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma.

Teishima, Jun; Murata, Daiki; Hasegawa, Yasuhisa; Moriyama, Hiroyuki; Mita, Koji; Matsubara, Akio

Teishima, Jun; Murata, Daiki; Hasegawa, Yasuhisa; Moriyama, Hiroyuki; Mita, Koji; Matsubara, Akio.

Afiliación

Teishima J; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Murata D; Department of Urology, Hiroshima-City Asa Citizens Hospital, Hiroshima, Japan.
Hasegawa Y; Department of Urology, Fukuyama Medical Center, Fukuyama, Japan.
Moriyama H; Department of Urology, JA Onomichi General Hospital, Onomichi, Japan.
Mita K; Department of Urology, Hiroshima-City Asa Citizens Hospital, Hiroshima, Japan.
Matsubara A; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Int J Urol ; 26(11): 1076-1077, 2019 11.

Article en En | MEDLINE | ID: mdl-31368187

Asunto(s)

Antineoplásicos Inmunológicos/uso terapéutico; Proteína C-Reactiva/metabolismo; Carcinoma de Células Renales/tratamiento farmacológico; Neoplasias Renales/tratamiento farmacológico; Nivolumab/uso terapéutico; Biomarcadores/sangre; Carcinoma de Células Renales/sangre; Humanos; Neoplasias Renales/sangre

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Carcinoma de Células Renales / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google